The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-3-(1-(3-methoxyphenyl)-3-(methylamino)propyl)-6-(1H-pyrazol-4-yl)quinazolin-4(3H)-one ID: ALA4753687
PubChem CID: 155594124
Max Phase: Preclinical
Molecular Formula: C22H23N5O2
Molecular Weight: 389.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNCCC(c1cccc(OC)c1)n1cnc2ccc(-c3cn[nH]c3)cc2c1=O
Standard InChI: InChI=1S/C22H23N5O2/c1-23-9-8-21(16-4-3-5-18(10-16)29-2)27-14-24-20-7-6-15(11-19(20)22(27)28)17-12-25-26-13-17/h3-7,10-14,21,23H,8-9H2,1-2H3,(H,25,26)
Standard InChI Key: GGOKZYYLQABONW-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
23.8797 -14.9352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8835 -15.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6006 -16.1712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5891 -14.5183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3069 -14.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3107 -15.7563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0299 -16.1673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.7502 -15.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7464 -14.9167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0225 -14.5011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0177 -13.6762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.4595 -14.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1753 -14.9118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1728 -15.7360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8879 -16.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6018 -15.7309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5963 -14.9017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8807 -14.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1649 -14.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0749 -13.6985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2677 -13.5275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.8556 -14.2425 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4082 -14.8552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4566 -13.6768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3066 -14.4844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.3008 -13.6594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1697 -13.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1668 -12.4369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8799 -12.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
9 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
1 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 23 2 0
23 19 1 0
12 24 1 0
25 26 1 0
17 25 1 0
24 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.46Molecular Weight (Monoisotopic): 389.1852AlogP: 2.99#Rotatable Bonds: 7Polar Surface Area: 84.83Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.95CX LogP: 2.22CX LogD: -0.25Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.00
References 1. Xu G,Gaul MD,Liu Z,DesJarlais RL,Qi J,Wang W,Krosky D,Petrounia I,Milligan CM,Hermans A,Lu HR,Huang DZ,Xu JZ,Spurlino JC. (2020) Hit-to-lead optimization and discovery of a potent, and orally bioavailable G protein coupled receptor kinase 2 (GRK2) inhibitor., 30 (23): [PMID:33038544 ] [10.1016/j.bmcl.2020.127602 ]